Short Read Sequencing Market Intelligence Report Covers Trends, Segments And Regional Growth

The short read sequencing market is positioned for remarkable expansion over the coming years, driven by technological advances and growing applications in healthcare and research. As demand for precise genomic information intensifies, this sector is becoming increasingly important for diagnostics, treatment, and scientific discovery. Below is a detailed overview of the current market valuation, key players, emerging trends, and segmentation that define this evolving industry.

Projected Market Valuation and Expansion Trajectory for the Short Read Sequencing Market
The short read sequencing market is on track for rapid growth, with its valuation expected to reach $17.75 billion by 2030. This corresponds to a robust compound annual growth rate (CAGR) of 17.9%. Several factors are propelling this expansion, including wider adoption of precision medicine initiatives, heightened demand for sequencing in oncology and rare diseases, and the broadening use of next-generation sequencing (NGS) in clinical diagnostics. Additional growth drivers include increased investments in genomics data infrastructure and the integration of artificial intelligence (AI) for enhanced sequence analysis. Upcoming trends likely to influence the market include the growing use of high-throughput sequencing platforms, demand for more affordable whole genome sequencing, the adoption of sophisticated bioinformatics pipelines, expansion into clinical and translational genomics, along with a focus on improving sequencing speed and accuracy.

Download a free sample of the Short Read Sequencing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11912&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Key Companies Leading the Short Read Sequencing Industry
The short read sequencing market features several prominent companies shaping its direction and innovation landscape. Among the leaders are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Illumina Inc., Agilent Technologies Inc., QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, BGI Genomics Co Ltd, MGI Tech Co. Ltd., 10x Genomics Inc., Zymo Research Corporation, Paragon Genomics Inc., Novogene Co. Ltd, Macrogen Inc., Fasteris SA, GenScript Biotech Corporation, Element Biosciences Inc., Singular Genomics Systems Inc., Ultima Genomics Inc., and GenapSys Inc.
One notable collaboration took place in March 2023, when QIAGEN N.V., a German provider specializing in sample and assay technologies including short read sequencing, partnered with Switzerland's Sophia Genetics SA. This alliance aims to enhance next-generation sequencing capabilities by combining QIAGEN's QIAseq reagent technology with SOPHiA's Digital Data Management (DDM) platform, improving tumor analysis and somatic variant detection.

Emerging Innovations Shaping the Short Read Sequencing Market
Industry players are increasingly focusing on hybrid long-/short-read sequencing assays, which expand analytical capabilities and improve genomic region accessibility. This hybrid approach merges long and short sequencing reads within a single workflow, providing higher genomic resolution while maintaining compatibility with existing high-throughput sequencing platforms.
For example, in March 2023, Illumina Inc., a U.S.-based leader in DNA sequencing technologies, introduced the Illumina Complete Long Read Prep, Human assay. This product integrates long-read functionality into current short-read sequencing instruments, enabling laboratories to obtain comprehensive genomic data without the need for separate long-read systems. It supports low DNA input and delivers high accuracy, enhancing analysis of complex genomic regions while simplifying workflows.

View the full Short Read Sequencing market report:
https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Detailed Breakdown of the Short Read Sequencing Market Segments
This market can be segmented across multiple dimensions to better understand its scope and application areas:
1) By Product: Instruments, Consumables, and Services
2) By Workflow: Pre-Sequencing, Sequencing, and Data Analysis
3) By Application: Clinical Investigation, Oncology, Reproductive Health, Consumer Genomics, Agri Genomics and Forensics, HLA Typing or Immune System Monitoring
4) By End Users: Academic Research, Hospitals and Clinics, Clinical Research, Pharmaceutical and Biotechnology Companies

Further subcategories include:
- Instruments such as Next-Generation Sequencing (NGS) Systems, Sequencing Platforms, and Library Preparation Systems
- Consumables comprising Reagents and Kits, Flow Cells, and Sample Preparation Consumables
- Services including Sequencing Services, Data Analysis Services, and Bioinformatics Services

With these segments, the short read sequencing market demonstrates a comprehensive approach that supports diverse applications and end-user needs, ensuring its continued growth and adaptation within the genomics field.

Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.